Logo image of VEEV

VEEVA SYSTEMS INC-CLASS A (VEEV) Stock Fundamental Analysis

NYSE:VEEV - New York Stock Exchange, Inc. - US9224751084 - Common Stock - Currency: USD

275.89  -5.75 (-2.04%)

After market: 275.89 0 (0%)

Fundamental Rating

7

Overall VEEV gets a fundamental rating of 7 out of 10. We evaluated VEEV against 36 industry peers in the Health Care Technology industry. Both the health and profitability get an excellent rating, making VEEV a very profitable company, without any liquidiy or solvency issues. VEEV is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings would make VEEV suitable for growth and quality investing!


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year VEEV was profitable.
VEEV had a positive operating cash flow in the past year.
Each year in the past 5 years VEEV has been profitable.
VEEV had a positive operating cash flow in each of the past 5 years.
VEEV Yearly Net Income VS EBIT VS OCF VS FCFVEEV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

1.2 Ratios

VEEV has a Return On Assets of 10.05%. This is amongst the best in the industry. VEEV outperforms 97.22% of its industry peers.
VEEV has a better Return On Equity (12.57%) than 97.22% of its industry peers.
VEEV's Return On Invested Capital of 10.20% is amongst the best of the industry. VEEV outperforms 91.67% of its industry peers.
The Average Return On Invested Capital over the past 3 years for VEEV is above the industry average of 6.38%.
The 3 year average ROIC (9.16%) for VEEV is below the current ROIC(10.20%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 10.05%
ROE 12.57%
ROIC 10.2%
ROA(3y)9.59%
ROA(5y)10.49%
ROE(3y)12.23%
ROE(5y)13.63%
ROIC(3y)9.16%
ROIC(5y)11.04%
VEEV Yearly ROA, ROE, ROICVEEV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

With an excellent Profit Margin value of 27.34%, VEEV belongs to the best of the industry, outperforming 97.22% of the companies in the same industry.
VEEV's Profit Margin has been stable in the last couple of years.
With an excellent Operating Margin value of 26.97%, VEEV belongs to the best of the industry, outperforming 97.22% of the companies in the same industry.
In the last couple of years the Operating Margin of VEEV has remained more or less at the same level.
The Gross Margin of VEEV (75.50%) is better than 80.56% of its industry peers.
In the last couple of years the Gross Margin of VEEV has remained more or less at the same level.
Industry RankSector Rank
OM 26.97%
PM (TTM) 27.34%
GM 75.5%
OM growth 3Y-2.45%
OM growth 5Y-0.44%
PM growth 3Y4.03%
PM growth 5Y-0.95%
GM growth 3Y0.79%
GM growth 5Y0.55%
VEEV Yearly Profit, Operating, Gross MarginsVEEV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

8

2. Health

2.1 Basic Checks

VEEV has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for VEEV has been increased compared to 1 year ago.
Compared to 5 years ago, VEEV has more shares outstanding
VEEV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
VEEV Yearly Shares OutstandingVEEV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
VEEV Yearly Total Debt VS Total AssetsVEEV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

An Altman-Z score of 19.89 indicates that VEEV is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 19.89, VEEV belongs to the best of the industry, outperforming 91.67% of the companies in the same industry.
VEEV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 19.89
ROIC/WACC0.97
WACC10.49%
VEEV Yearly LT Debt VS Equity VS FCFVEEV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.3 Liquidity

VEEV has a Current Ratio of 4.60. This indicates that VEEV is financially healthy and has no problem in meeting its short term obligations.
VEEV has a Current ratio of 4.60. This is amongst the best in the industry. VEEV outperforms 86.11% of its industry peers.
VEEV has a Quick Ratio of 4.60. This indicates that VEEV is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 4.60, VEEV belongs to the top of the industry, outperforming 86.11% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.6
Quick Ratio 4.6
VEEV Yearly Current Assets VS Current LiabilitesVEEV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 30.39% over the past year.
VEEV shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 24.72% yearly.
Looking at the last year, VEEV shows a quite strong growth in Revenue. The Revenue has grown by 14.78% in the last year.
Measured over the past years, VEEV shows a quite strong growth in Revenue. The Revenue has been growing by 19.99% on average per year.
EPS 1Y (TTM)30.39%
EPS 3Y21.12%
EPS 5Y24.72%
EPS Q2Q%31.33%
Revenue 1Y (TTM)14.78%
Revenue growth 3Y14.06%
Revenue growth 5Y19.99%
Sales Q2Q%16.71%

3.2 Future

Based on estimates for the next years, VEEV will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.26% on average per year.
VEEV is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.45% yearly.
EPS Next Y16.83%
EPS Next 2Y13.26%
EPS Next 3Y14.48%
EPS Next 5Y13.26%
Revenue Next Year13.46%
Revenue Next 2Y12.51%
Revenue Next 3Y12.79%
Revenue Next 5Y13.45%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
VEEV Yearly Revenue VS EstimatesVEEV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B
VEEV Yearly EPS VS EstimatesVEEV Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5 10 15

4

4. Valuation

4.1 Price/Earnings Ratio

VEEV is valuated quite expensively with a Price/Earnings ratio of 38.97.
Based on the Price/Earnings ratio, VEEV is valued cheaply inside the industry as 83.33% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.30. VEEV is valued slightly more expensive when compared to this.
VEEV is valuated quite expensively with a Price/Forward Earnings ratio of 32.54.
69.44% of the companies in the same industry are more expensive than VEEV, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.76, VEEV is valued a bit more expensive.
Industry RankSector Rank
PE 38.97
Fwd PE 32.54
VEEV Price Earnings VS Forward Price EarningsVEEV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

63.89% of the companies in the same industry are more expensive than VEEV, based on the Enterprise Value to EBITDA ratio.
75.00% of the companies in the same industry are more expensive than VEEV, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 37.91
EV/EBITDA 44.06
VEEV Per share dataVEEV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of VEEV may justify a higher PE ratio.
VEEV's earnings are expected to grow with 14.48% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.32
PEG (5Y)1.58
EPS Next 2Y13.26%
EPS Next 3Y14.48%

0

5. Dividend

5.1 Amount

VEEV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

VEEVA SYSTEMS INC-CLASS A

NYSE:VEEV (7/11/2025, 8:04:00 PM)

After market: 275.89 0 (0%)

275.89

-5.75 (-2.04%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)05-28 2025-05-28/amc
Earnings (Next)08-26 2025-08-26/amc
Inst Owners86.41%
Inst Owner Change0.01%
Ins Owners8.48%
Ins Owner Change0.04%
Market Cap44.96B
Analysts76.84
Price Target298.48 (8.19%)
Short Float %3.33%
Short Ratio3.33
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.53%
Min EPS beat(2)7.97%
Max EPS beat(2)11.08%
EPS beat(4)4
Avg EPS beat(4)7.79%
Min EPS beat(4)3.51%
Max EPS beat(4)11.08%
EPS beat(8)8
Avg EPS beat(8)5.6%
EPS beat(12)11
Avg EPS beat(12)5.76%
EPS beat(16)15
Avg EPS beat(16)5.59%
Revenue beat(2)2
Avg Revenue beat(2)1.38%
Min Revenue beat(2)1.09%
Max Revenue beat(2)1.66%
Revenue beat(4)2
Avg Revenue beat(4)0.38%
Min Revenue beat(4)-0.82%
Max Revenue beat(4)1.66%
Revenue beat(8)2
Avg Revenue beat(8)-0.37%
Revenue beat(12)3
Avg Revenue beat(12)-0.42%
Revenue beat(16)4
Avg Revenue beat(16)-0.39%
PT rev (1m)1.55%
PT rev (3m)9.65%
EPS NQ rev (1m)1.22%
EPS NQ rev (3m)5.91%
EPS NY rev (1m)3.76%
EPS NY rev (3m)3.17%
Revenue NQ rev (1m)0.34%
Revenue NQ rev (3m)2.31%
Revenue NY rev (1m)0.22%
Revenue NY rev (3m)1.35%
Valuation
Industry RankSector Rank
PE 38.97
Fwd PE 32.54
P/S 15.74
P/FCF 37.91
P/OCF 37.35
P/B 7.24
P/tB 7.84
EV/EBITDA 44.06
EPS(TTM)7.08
EY2.57%
EPS(NY)8.48
Fwd EY3.07%
FCF(TTM)7.28
FCFY2.64%
OCF(TTM)7.39
OCFY2.68%
SpS17.52
BVpS38.12
TBVpS35.17
PEG (NY)2.32
PEG (5Y)1.58
Profitability
Industry RankSector Rank
ROA 10.05%
ROE 12.57%
ROCE 12.21%
ROIC 10.2%
ROICexc 267.97%
ROICexgc N/A
OM 26.97%
PM (TTM) 27.34%
GM 75.5%
FCFM 41.53%
ROA(3y)9.59%
ROA(5y)10.49%
ROE(3y)12.23%
ROE(5y)13.63%
ROIC(3y)9.16%
ROIC(5y)11.04%
ROICexc(3y)59.89%
ROICexc(5y)59.49%
ROICexgc(3y)196.73%
ROICexgc(5y)318.62%
ROCE(3y)10.96%
ROCE(5y)13.22%
ROICexcg growth 3Y-36.21%
ROICexcg growth 5Y-13.57%
ROICexc growth 3Y1.45%
ROICexc growth 5Y14.29%
OM growth 3Y-2.45%
OM growth 5Y-0.44%
PM growth 3Y4.03%
PM growth 5Y-0.95%
GM growth 3Y0.79%
GM growth 5Y0.55%
F-Score7
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 44.1%
Cap/Sales 0.63%
Interest Coverage 250
Cash Conversion 148.48%
Profit Quality 151.89%
Current Ratio 4.6
Quick Ratio 4.6
Altman-Z 19.89
F-Score7
WACC10.49%
ROIC/WACC0.97
Cap/Depr(3y)59.59%
Cap/Depr(5y)52.02%
Cap/Sales(3y)0.83%
Cap/Sales(5y)0.77%
Profit Quality(3y)158.47%
Profit Quality(5y)158.74%
High Growth Momentum
Growth
EPS 1Y (TTM)30.39%
EPS 3Y21.12%
EPS 5Y24.72%
EPS Q2Q%31.33%
EPS Next Y16.83%
EPS Next 2Y13.26%
EPS Next 3Y14.48%
EPS Next 5Y13.26%
Revenue 1Y (TTM)14.78%
Revenue growth 3Y14.06%
Revenue growth 5Y19.99%
Sales Q2Q%16.71%
Revenue Next Year13.46%
Revenue Next 2Y12.51%
Revenue Next 3Y12.79%
Revenue Next 5Y13.45%
EBIT growth 1Y45.85%
EBIT growth 3Y11.27%
EBIT growth 5Y19.47%
EBIT Next Year18.21%
EBIT Next 3Y19.68%
EBIT Next 5Y16.63%
FCF growth 1Y49.87%
FCF growth 3Y12.54%
FCF growth 5Y19.82%
OCF growth 1Y49.45%
OCF growth 3Y12.55%
OCF growth 5Y20.04%